QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 capital-one-initiates-coverage-on-biomea-fusion-with-overweight-rating-announces-price-target-of-25

Capital One analyst Naureen Quibria initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Overweight rating and announces...

 citigroup-maintains-buy-on-biomea-fusion-lowers-price-target-to-22

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $45 to...

 hc-wainwright--co-reiterates-buy-on-biomea-fusion-maintains-15-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $15 price t...

 biomea-fusion-q2-eps-103-beats-107-estimate

Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.07)...

 hc-wainwright--co-reiterates-buy-on-biomea-fusion-maintains-15-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $15 price t...

 truist-securities-downgrades-biomea-fusion-to-hold

Truist Securities analyst Robyn Karnauskas downgrades Biomea Fusion (NASDAQ:BMEA) from Buy to Hold.

 citigroup-maintains-buy-on-biomea-fusion-lowers-price-target-to-45

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price target from $90 to...

 hc-wainwright--co-maintains-buy-on-biomea-fusion-lowers-price-target-to-15

HC Wainwright & Co. analyst Joseph Pantginis maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and lowers the price targe...

 why-biomea-fusion-bmea-stock-is-down-60

Biomea Fusion shares are trading lower by 62.7% during Friday's session. The company received notice from the FDA that Its ...

 piper-sandler-maintains-overweight-on-biomea-fusion-lowers-price-target-to-10

Piper Sandler analyst Joseph Catanzaro maintains Biomea Fusion (NASDAQ:BMEA) with a Overweight and lowers the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION